Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

PharmaCielo to Produce 500-Year-Old Cannabis Strain in the Ancestral Territory of the Arhuaco

The Company has partnered with indigenous peoples in Colombia such as the Arhuaco, to bring opportunity to historically disadvantaged areas of the country through the production and sale of legal cannabis.

Read more ››
By: PR Newswire Association LLC. - 13 Dec 2018

Beleave Announces GMP Certification and Operational Updates

TORONTO, Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification.

Read more ››
By: PR Newswire Association LLC. - 13 Dec 2018
Related companies:  Beleave Inc.

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2018
Related companies:  ESSA Pharma Inc.

AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  AMAG PHARMACEUTICALS, INC.

Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Avinger, Inc.

Bellicum Pharmaceuticals Appoints Atabak Mokari as Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Bellicum Pharmaceuticals, Inc.

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  NeoGenomics Inc.

Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Antares Pharma, Inc

Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Rhythm Pharmaceuticals Inc.

Hi Fidelity Genetics Closes Series A Financing to Automate Plant Breeding

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018

ProQR Announces Strategic Changes to the Management Team and Key New Hires

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  ProQR Therapeutics NV

Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Altimmune, Inc.

HEXO Corp reports $6.7 million in gross revenue for the first quarter of new fiscal year

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Orchard Therapeutics Limited

Inspire’s Health Profiles Identifies the Insights of Patients to Unlock Research Gaps

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018

Sport Endurance Appoints Michael Young to Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018

Canntab Partners with Leading Surgeon to Conduct Pain Management Trial -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018

XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  XBiotech Inc.

CLS Holdings USA Closes approximately $12 Million Private Placement of Convertible Debentures

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018

NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis

Read more ››
By: Nasdaq / GlobenewsWire - 13 Dec 2018
Related companies:  Cynata Therapeutics Limited
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑